The increasing usage of high throughput sequencing in personalized medicine brings new challenges to the realm of healthcare informatics. Patient records need to accommodate data of unprecedented size and complexity as well as keep track of their production process. In this work we present a solution for integrating genomic data into electronic health records via openEHR archetypes. We introduce new genomics-specific archetypes based on the popular variant call format and show their applicability to a practical use case. Finally, we discuss their structure in comparison with the HL7 R FHIR R standard.
Introduction
Next generation sequencing (NGS) techniques have recently enabled a substantial advancement in the treatment of genetic disorders, paving the way for personalized therapies based on each patient's specific set of genomic variations. Whole-exome (WES) and whole-genome sequencing (WGS) have become increasingly common in the past years, thanks mainly to the progress and cost reduction in high-throughput sequencing technologies 1, 2 . This trend suggests that genomic data are going to play an increasingly important role within medical practice in the near future.
Entities related to a patient's clinical history can be modeled according to a spoke-hub paradigm, where the different actors (such as clinicians, specialists, hospitals, labs and the patient itself) all revolve around the Electronic Health Record (EHR), the central collection point of all clinical data provided by each actor. Due to its high relevance in modern healthcare, genomic are establishing a common ground for communication between technicians and clinicians and addressing the frequent advancement of clinical knowledge. In the case of genomic content, this is further exacerbated by the size and structure issues discussed above. The multi-level openEHR approach helps mitigate these problems by separating structure and content: only the first modeling level (RM classes) is implemented in software, while formal definitions of clinical content (archetypes and templates) are external. This means that EHR repositories can be developed independently from the content they will store. Moreover, EHR systems can be kept small, maintainable and self-adaptable to archetypes and templates that may be developed in the future 7 . Finally, this decoupling facilitates contributions by non-technical professionals, who can formalize their clinical knowledge via user-friendly modeling tools.
Structured approach
Integrating NGS data into EHRs is hard due to two main reasons 3 :
• their size (up to hundreds of gigabytes) and complexity (e.g., irregular degree of nesting in laboratory test outputs);
• the way they are generated and manipulated, with processing pipelines where each step depends on a multitude of software parameters and resource databases.
Currently available EHR systems typically collect three types of data: granular (e.g., laboratory test results), text (e.g., pathology reports) and media (e.g., medical imaging). As mentioned earlier, due to the lack of specific data structures genomic data is often included in text form, which makes their analysis and reuse particularly cumbersome. The adoption of a structured format would greatly simplify the processing and transfer of clinical genomic data, effectively enhancing its medical value. The chosen format should enable the efficient management of complex clinical content by organizing it into standard reusable entities. At the same time, it should allow the specification of data semantics, while ensuring that the original meaning is preserved in case of sharing. Finally, it should preserve the data history, with regard to both the operations performed and the auxiliary resources involved in the transformation process (such as external databases, genomic references, etc.). In the remainder of this paper we show how to use the openEHR approach to address these issues.
Materials and methods

Genomic data
WGS and WES have rapidly changed research on the genetic causes of rare and complex diseases.
Independently from the technology used, NGS data analysis can be broken down into two main steps 8 : the analytic wet bench process and the bioinformatic analysis of sequence data (Fig. 1 ). The process starts with DNA extraction and its fragmentation into small pieces. NGS instruments produce billions of shorts sequence reads (strings representing ordered DNA nucleotides in a fragment) simultaneously in a single machine run. Reads are subsequently aligned (mapped) to a reference sequence through dedicated software, a computationally intensive operation due to the large size of the reference. Aligned reads are then processed to correct for technical biases and, finally, genomic variants (the differences between the sample and the reference) are identified and reported, along with additional information such as the coverage depth (average number of reads that align to known reference bases) and accuracy measures. Due to the large amount of variants that can be detected, generating useful results requires one or more filtering steps to prioritize potential disease-causing mutations 9, 10, 11, 12 . This is commonly done by annotating variants with references to public databases such as dbSNP 13 . Common scenarios in human NGS data analysis include the discovery of disease-associated variant(s) for mendelian disor-ders, the identification of candidate genes responsible for complex diseases and the detection of constitutional and somatic mutations in cancer studies 9 .
Genomic data can be seen as a multilayer structure composed of three levels:
• Raw data, the direct output of the sequencing process, consist of millions of short sequence reads, text strings containing the detected DNA nucleotides together with their associated quality scores (statistical predictions of accuracy).
• Derived data represents the observed variants, along with additional measurements (e.g., coverage);
• Annotated data corresponds to variants filtered according to additional a-priori information, as discussed above.
With respect to Fig. 1 , the first level falls within the wet bench block, while the other two are part of the bioinformatic pipeline. A common bioinformatic workflow for variant identification from NGS data includes the following steps 14 (Fig. 2 ):
• Alignment: short reads are aligned to the reference to produce a file in SAM/BAM format 15 , sorted by genomic coordinate. Initial mappings are further processed to address technical biases (removal of duplicate sequences, recalibration of base quality scores).
• Variant calling: alignment files output by the previous step are processed to detect variations between the sample and the reference. Since variations may also arise from mapping and sequencing artifacts, variant calling software should carefully balance sensi-tivity to minimize false positives. The output, typically in tabular format, contains the list of variant sites, the individual genotypes and additional information such as coverage and genotyping accuracy.
• Variant annotation: assigning functional information to genomic variants is a crucial step in the analysis of sequencing data, enabling researchers to focus on the potential disease-causing variants. Many types of biological information can be associated to variants: the position in transcript sets (e.g., UCSC, RefGene, GENCODE, ENSEMBL), whether the variant is known or novel based on dbSNP, the prediction of their impact on the protein structure and function according to different models (e.g., SIFT, PolyPhen2, LRT, MutationTaster, MutationAssessor, FATHMM), sequence conservation (e.g., PhyloP, PhastCons), known associations of the variant with diseases (e.g., OMIM, ClinVar) and allele frequency in reference populations (e.g., ESP6500, 1000 Genomes Project, gnomAD). The openEHR model allows to achieve this through the archetypes formalism.
OpenEHR modeling approach
As discussed above, genetic data sets are produced via complex pipelines that involve the use of different algorithms, parameters and reference entities. To provide a comprehensive and reusable model for genomic data, archetypes should be able to keep track of all this information in a structured way. Since all of these elements can change over time, to ensure reproducibility we include this information as external references in our model. Common openEHR modeling practice follows (possibly with recursion) these steps:
• define the data to be represented;
• search model repositories for reusable archetypes and, possibly, map existing archetype nodes with clinical attributes;
• create new archetypes or specialize existing ones for the specific domain being modeled.
In our case, the model has to represent the output of the bioinformatic pipeline, i.e., information about the variants detected at specific positions in the genome. Due to its wide adoption for the representation of genomic data, we have designed our archetypes to mirror the Variant Call Format (VCF) 16 . As shown in Fig. 4 , a VCF file consists of meta-information lines, a header line and data lines (body). If there are multiple alternate alleles called on at least one sample for a given position, these are reported as a comma separated list under the ALT field. The INFO field (see Fig. 5 ) gives additional information on the observed variant, in a format specified in the meta-information. Sample-specific information (such as coverage or genotype accuracy), is encoded in the FORMAT column, whose structure is also specified in the meta-information block. In addition to the mandatory ones, VCF allows to specify additional fields to accommodate specific domain anno- 3 Results Table 1 ). 
OBSERVATION-Genetic Test Result
CLUSTER-Genetic Findings
The Genetic Findings cluster (see Fig. 8 ) is meant to be used in the "test findings" slot of Genetic 
CLUSTER-Sequence Variation and supplementary clusters
The Sequence Variation archetype (see Fig. 9 ) is designed to contain the same data found in a VCF row. The position of the observation in the genome is given with respect to a reference sequence specified in the Reference Sequence archetype (Fig. 10 ). Following the nomenclature proposed by the Human Genome Variation Society (HGVS) 1 , the most common variant types are: substitution, deletion, duplication, insertion, inversion, conversion, insertion-deletion (indel) and repeated sequence 21 . We developed a new cluster archetype for each of the above types (examples are shown in Fig. 11 and 12 ).
Discussion
Real use case application
WES has emerged as a powerful tool for the diagnosis of rare mendelian disorders, especially where standard approaches have failed. This technique focuses on the protein-coding regions of the genome that are more likely to harbour disease-causing variants associated with a particular phenotype. Initially used for research activities, WES is now entering clinics for diagnostic purposes, thanks to the decreasing costs of NGS technologies. A typical study design for the identification of pathogenic variants in rare diseases includes the patient and its parents, and optionally additional family members (affected or not). In this report, we use results related to the WES of one family member to show how openEHR archetypes can successfully describe the genomic information obtained from an NGS-based genetic test (Tables 2 and 5 ). Table 5 The comparison was carried out considering three types of data: context, derived and objective.
Context data and interpretations
In the FHIR R model, information about the context of the genetic test performed, the devices used, the specimen, the patient and the performer is given both in the Observation resource and in the Sequence resource (as a reference to another external resource). Similarly, in the openEHR model the Genetic Test Result archetype contains slots to include cluster archetypes (e.g., Specimen, Medical Device) that provide context information. The difference is that while in FHIR R this information is repeated in multiple places, the recursively nested openEHR approach allows to refer to the same entity multiple times, avoiding redundancy.
Genetic data are typically complemented by subjective information such as diagnosis or generic comments. In the FHIR R model, these are mainly represented within the Genetics profile of the Diagnostic Report resource. In our model, this type of data could be included in the Genetic Test Result archetype.
Derived data
Derived data consist of annotations from the bioinformatic analysis: transcript annotations, impact prediction, sequence conservation, etc. In the openEHR model these items are represented within the Genetic Findings cluster archetype, and the range of representable annotations can be broadened via extension slots. At present, FHIR R does not include explicit references to this type of data.
Objective data describe the observed sequence variations. In the FHIR R standard, these elements can be found both in the Sequence (e.g., reference sequence, variant, quality) and in the Observation-Genetics resource (e.g., DNA variant type and ID, gene, allelic state), while in our model they are all included in the Sequence Variation archetype, in order to isolate the interpretative aspects from the purely objective variant data.
Our approach differs from the FHIR R one in two main respects: reference sequence and variant description. In FHIR R , the reference sequence can be represented by the same Sequence resource used to describe the sample sequence, while in our model it is made available via a link to an external entity (repository, accession and version). In FHIR R , the observed variant is also represented within the Sequence resource through the range of positions affected by the change(s), the reference allele and the observed one and the CIGAR string 15 , while in our model we use a different archetype for each variant type in the HGVS specifications.
Modeling issues
The first challenge encountered during the modeling process was how to represent the results of genetic tests conducted on more than one sample. This happens, for instance, in rare disease studies where patient data is more useful if compared to data from family members, or in oncology when cancer cells are compared to non-cancer cells from the same patient. The archetypes presented here are meant to be used for a single sample, with the assumption that any relationships with other samples are handled at a higher level, i.e., at the composition level.
Another critical aspect concerns the representation of the different types of variant. A simple approach would be to store the reference nucleotide, start position and observed nucleotide(s).
This method is very similar to the one adopted in VCF files and works well for single nucleotide substitutions, but can be confusing for more complex variant types. For instance, for simple deletions the VCF REF and ALT strings must include the base before the event, while this is not required for complex substitutions 16 . To avoid this kind of ambiguity, we used a specific archetype to describe each type of variant.
Related work
Integration of genomic data into EHRs is the subject of several ongoing activities.
The EHR Integration (EHRI) workgroup of the Electronic Medical Records and Genomics (eMERGE) network aims to develop standards and methods for incorporating genomic data into EHRs and optimizing their utilization 24, 25 . Finally, a first draft of archetypes for genomic data has recently been published in the Norwegian instance of the CKM by the Nasjonal IKT 31 . It consists of five archetypes that describe the patient's genome, the output of a genetic assessment, the protocol of a genetic laboratory analysis, the description of a variation and of the two alleles. Even though the model is well designed and accurate, it does have a few shortcomings. The Genetic Lab Analysis archetype, which describes the protocol used to perform a genetic test, does not support contextual information such as the patient's clinical conditions. In contrast, we represented genetic test results with a specialization of the existing Laboratory Test Result archetype, which contains an accurate description of both context data and the adopted protocol. Moreover, this is in line with openEHR best practice on resources reuse through specialisation 32 . The Genetic Variant archetype, together with its Allele Details extension, represents information about variations via plain text strings: a characterization (normal or pathogenic), a generic description, one or more reference sequences, etc.
In our model, instead, we employ versionable entities (reference sequence, variant ID, etc.) that link to external databases, and we represent each variant type in structured form via a separate cluster archetype. This improves machine readability and makes the archetype more flexible and easily adaptable to the rapid changes in reference sequences and bioinformatic tools. Finally, the IKT model lacks annotations and tools to enable variant filtering and parameter calculation, which we include in the cluster archetype that represents test findings.
Conclusions and future work
We have presented a model for representing genomic content (sequence variation analysis) in a structured form through openEHR archetypes, with the main goals of being machine readable, reusable and shareable. Moreover, each versionable resource or tool involved in the data production process is linked as an external object, allowing to keep track of the particular revision of each instance. We have assessed the feasibility of our approach by applying it to the rare diseases use case. Finally, we have discussed its interoperability with HL7 R FHIR R .
The archetypes described here are available at https://github.com/crs4/openehr-genomics.
In the future, we plan to integrate their use in our production NGS analysis pipelines to formalize the results made available to clinical researchers.
